CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 21,516 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,477 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,077 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 7,146 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 69,994 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operating Officer sold 2,500 shares at $18.69 ($46,725)
- 4 Open-market sale President & CEO sold 12,500 shares at $18.56 ($231,960)
- 4 Open-market sale President & CEO sold 825,000 shares at $18.00 ($14,850,000)
- 4 Open-market sale Chief Financial Officer sold 3,159 shares at $19.59 ($61,872)
- 4 Open-market sale Chief Financial Officer sold 3,112 shares at $18.88 ($58,757)
- 4 Open-market sale Chief Operating Officer sold 2,500 shares at $19.26 ($48,150)
- 4 Open-market sale Chief Financial Officer sold 1,388 shares at $19.02 ($26,400)
- 4 Open-market sale Chief Financial Officer sold 3,159 shares at $19.00 ($60,021)
- 4 Open-market sale Chief Operating Officer sold 2,500 shares at $18.40 ($46,000)
- 4 Open-market sale Chief Financial Officer sold 740 shares at $21.78 ($16,117)
Page 10 of 20 · 399 filings